An update from Grand Pharmaceutical Group Limited ( ($HK:0512) ) is now available. Grand Pharmaceutical Group has reported that its ...

Three world-leading nuclear medicine organizations--the SNMMI Clinical Trials Network (SNMMI-CTN), the Australasian ...

Louvain-La-Neuve, Belgium, 19 December 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, acquires ...

ANSTO has reached a major milestone in advancing its new Nuclear Medicine Manufacturing Facility (NMMF) at Lucas Heights-our ...

Some of the most innovative uses of artificial intelligence in healthcare today are in the field of nuclear medicine, and thanks to AI, nuclear medicine is demonstrating great potential for cancer ...

Nuclear medicine is a specialized area of radiology used to help diagnose and treat abnormalities early in the progression of a disease. This imaging captures medical information that would otherwise ...

Doctors have used radioiodine therapy, a type of nuclear medicine treatment, since the 1940s. Now, a new generation of radiopharmaceuticals offers expanded treatment options for people with some types ...

The NMMIS program is accredited by the Joint Review Committee on Educational Programs in Nuclear Medicine Technology (JRCNMT). Post-Baccalaureate Accreditation approval is maintained through 2024 from ...

Iran has launched three new radiopharmaceutical innovations and its National Nuclear Education Network in Tehran.

The Indian government defends its new nuclear energy bill, SHANTI, amidst opposition criticism. The legislation aims to ...

A former Assistant Director of the Nigeria’s Federal Ministry of Health (FMOH), Dr Ofodire Emeka, has accused senior officials of deliberate obstruction, persecution and administrative abuse following ...

Nuclear medicine technologists operate equipment that detects and maps a radioactive drug within a patient’s body to create diagnostic images. The images are then produced on a computer screen or on ...